Therapeutically promising PNA complementary to a regulatory sequence for c-myc: Pharmacokinetics in an animal model of human Burkitt's lymphoma

Oligonucleotides

Volumn 15, Issue 2, 2005, Pages 85-93

  Boffa, Lidia C ^a   Cutrona, Giovanna ^a   Cilli, Michele ^a   Mariani, Maria Rita ^a,b   Matis, Serena ^a,c   Pastorino, Martina ^a,c   Damonte, Gianluca ^c   Millo, Enrico ^d   Roncella, Silvio ^e   Ferrarini, Manlio ^a,c  

^a UNIVERSITY OF GENOA   (Italy)

^b CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d G GASLINI INSTITUTE   (Italy)

^e S Bartolomeo Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; IMMUNOGLOBULIN; PEPTIDE NUCLEIC ACID; PEPTIDE NUCLEIC ACID E MU; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BURKITT LYMPHOMA; CELL PROLIFERATION; DNA SEQUENCE; DRUG HALF LIFE; DRUG MECHANISM; DRUG TISSUE LEVEL; ENHANCER REGION; FEMALE; GENE LOCATION; GENE LOCUS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRON; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; PRIORITY JOURNAL; REGULATORY SEQUENCE; SCID MOUSE; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; BURKITT LYMPHOMA; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, SCID; PEPTIDE NUCLEIC ACIDS; PROTO-ONCOGENE PROTEINS C-MYC;

ANIMALIA;

EID: 22044445097     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2005.15.85     Document Type: Article

References (18)

1. CUTRONA, G., CARPANETO E.M., PONZANELLI, A., ULIVI, M., MILLO, E., SCARFÌ, S., RONCELLA, S., BENATTI, U., BOFFA, L.C., and FERRARINI, M. (2003). Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the Eμ enhancer. Cancer Res. 63, 6144-6148.
2. CUTRONA, G., CARPANETO, E.M., ULIVI, M., RONCELLA, S., LANDT, O., FERRARINI, M., and BOFFA, L.C. (2000). Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal. Nat. Biotechnol. 18, 300-303.
3. HECKL, S., PIPKORN, R., WALDECK, W., SPRING, H., JENNE, J., VON DER LIETH. C.W., CORBAN-WILHELM, H., DEBUS, J., and BRAUN, K. (2003). Intracellular visualization of prostate cancer using magnetic resonance imaging. Cancer Res. 63, 4766-4772.
4. JANSEN, K., and RICHELSON, E. (2000). Detection of peptide nucleic acids in tissue extracts of treated animals by gel mobility shift assay. J. Biochem. Biophys. Methods 42, 31-34.
5. KOPPELHUS, U., and NIELSEN, P.E. (2003). Cellular delivery of peptide nucleic acid (PNA). Adv. Drug Deliv. Rev. 55, 267-280.
6. KRISTENSEN, E. (2000). In vitro and in vivo studies on the pharmacokinetics and metabolism of PNA constructs in rodents. In: Methods in Molecular Biology. Peptide Nucleic Acids: Methods and Protocols. P.E. Nielsen, ed. (Humana Press Inc. Totowa NJ), 208, 259-269.
7. LEE, H.J., BOADO, R.J., BRAASH, D.A., COREY, D.R., and PARDRIDGE, W.M. (2002). Imaging gene expression in the brain in vivo in a transgenic mouse model of Huntington's disease with an antisense radiopharmaceutical and drug-targeting technology. J. Nucl. Med. 43, 948-956.
8. MAGNANI, M., CASABIANCA, A., FRATERNALE, A., BRANDI, G., GESSANI, S., WILLIAMS, R. GIOVINE, M., DAMONTE, G., DE FLORA, A., and BENATTI, U. (1996). Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection. Proc. Natl. Acad. Sci. USA 93, 4403-4408.
9. MCMAHON, B.M., MAYS, D., LIPSKY, J., STEWART, J.A., FAUQ, A., and RICHELSON, E. (2002a). Pharmacokinetics and tissue distribution of a peptide nucleic acid after intravenous administration. Antisense Nucleic Acid Drug Dev. 12, 65-70.
10. MCMAHON, B.M., STEWART, J.A., BITNER, M.D., FAUQ, A., MCCORMICK, D.J., and RICHELSON, E. (2002b) Peptide nucleic acids specifically cause antigene effects in vivo by systemic injection. Life Sci. 71, 325-337.
11. NIELSEN, P.E. (2002). PNA technology. Methods Mol. Biol. 208, 3-26.
12. PARDRIDGE, W.M., BOADO, R.J., and KANG, Y.S. (1995). Vector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood brain barrier in vivo. Proc. Natl. Acad. Sci. USA 92, 5592-5596.
13. PAROO, Z., and COREY, D.R. (2003). Imaging gene expression using oligonucleotides and peptide nucleic acids. J. Cell. Biochem. 90, 437-442.
14. RONCELLA, S., CUTRONA, G., FAVRE, A., ULIVI, M., FAIS, F., SIGNORINI, A., GROSSI, C.E., CHIORAZZI, N., and FERRARINI, M. (1996). Apoptosis of Burkitt's lymphoma cells induced by specific interaction of surface IgM with a self-antigen: Implications for lymphomagenesis in acquired immunodeficiency syndrome. Blood 88, 599-608.
15. SCARFÌ, S., GIOVINE, M., GASPARINI, A., DAMONTE, G., MILLO, E., POZZOLINI, M., and BENATTI, U. (1999). Modified peptide nucleic acids are internalized in mouse macrophages RAW 264.7 and inhibit inducible nitric oxide synthase. FEBS Lett. 451, 264-268.
16. SHI, N., BOADO, R.J., and PARDRIDGE, W.M. (2000). Anti-sense imaging of gene expression in the brain in vivo. Proc. Natl. Acad. Sci. USA 97, 14709-14714.
17. TIAN, X., ARUVA, M.R., RAO, P.S., QIN, W., READ, P., SAUTER, E.R., THAKUR, M.L., and WICKSTROM, E. (2003.) Imaging oncogene expression. Ann. NY Acad. Sci. 1002, 165-188.
18. VOSE, J.M., CHIU, B.C., CHESON B.D., DANCEY, J., and WRIGHT, J. (2002). Update on epidemiology and therapeutics for non-Hodgkin's lymphoma. Hematology 62, 242-262.